0001209191-20-007514.txt : 20200207 0001209191-20-007514.hdr.sgml : 20200207 20200207162046 ACCESSION NUMBER: 0001209191-20-007514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200205 FILED AS OF DATE: 20200207 DATE AS OF CHANGE: 20200207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Jatin CENTRAL INDEX KEY: 0001782186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 20587738 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS, INC. STREET 2: 85 WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-05 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001782186 Shah Jatin C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVE. NEWTON MA 02459 0 1 0 0 EVP, Chief Medical Officer Stock Option (right to buy) 18.00 2020-02-05 4 A 0 60600 0.00 A 2030-02-04 Common Stock 60600 60600 D Restricted Stock Units 2020-02-05 4 A 0 22600 0.00 A Common Stock 22600 22600 D This option was granted on February 5, 2020. The shares underlying this option vest as to 25% of the shares on February 5, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock. The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date. /s/ Christopher B. Primiano as Attorney-in-Fact for Jatin Shah 2020-02-07